Policy / Regulatory

NMPA Publishes 110th Batch of Chemical Generic Drug Reference Listed Drug Catalog – 28 New Specifications Added

NMPA Publishes 110th Batch of Chemical Generic Drug Reference Listed Drug Catalog – 28 New Specifications Added

The National Medical Products Administration (NMPA) has released the 110th batch of the Catalog of Reference Listed Drugs (RLD) for Chemical Generic Drugs, adding 28 new drug specifications and providing…

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Beijing Releases List of Novel Drugs and Technologies Exempt from CHS-DRG Payment Scheme
RDLReimbursement payment standards

Beijing Releases List of Novel Drugs and Technologies Exempt from CHS-DRG Payment Scheme

NMPA's CDE Releases Draft Proposal for Benefit-Risk Assessment in Global Drug Development
CDEMRCT

NMPA’s CDE Releases Draft Proposal for Benefit-Risk Assessment in Global Drug Development

Guangdong Province Releases List of Urgent Clinical Drugs and Devices for GBA Cities
Greater Bay Area

Guangdong Province Releases List of Urgent Clinical Drugs and Devices for GBA Cities

Beijing Conference Outlines 2025 Healthcare Security Goals and 2024 Progress
BMINHSA (prev. SMIA)

Beijing Conference Outlines 2025 Healthcare Security Goals and 2024 Progress

Show More